100 results
Page 3 of 5
8-K
EX-99.1
nytzgq0kc rf8iiya5jy
18 Nov 20
Hepion Pharmaceuticals Data Safety Monitoring Board Recommends Continuation of Phase 2a 'AMBITION' Clinical Trial for Treatment of Advanced NASH
8:29am
FWP
e83cp t2hqc6peeoew
12 Nov 20
Free writing prospectus
5:27pm
8-K
EX-99.1
r0ngydnvgya
1 Oct 20
Regulation FD Disclosure
4:27pm
8-K
EX-99.1
5j4q p4hkd
7 Jul 20
Hepion Pharmaceuticals Announces Preclinical Data Supporting Novel Two-Pronged Approach to Treating COVID-19 with CRV431
8:26am
8-K
EX-99.1
l1ip6
15 Jun 20
Regulation FD Disclosure
9:22am
8-K
EX-99.1
al6unsru yjtb69q4l
19 May 20
Regulation FD Disclosure
9:51pm
8-K
EX-99.1
pru 9335qkguy
19 May 20
Other Events
8:12am
424B5
qqfpcgn3dd
26 Mar 20
Prospectus supplement for primary offering
9:33pm
8-K
EX-99.1
ww1295dgh32k1gpnl5
11 Mar 20
Regulation FD Disclosure
4:05pm
424B5
m2i3d s16x
12 Feb 20
Prospectus supplement for primary offering
9:05am
8-K
EX-99.1
hroci gpb
7 Feb 20
Regulation FD Disclosure
4:46pm
8-K
EX-99.1
w0fi0udgnvptdsu5o00
3 Dec 19
Regulation FD Disclosure
4:15pm
8-K
5v3fjelf
8 Oct 19
Departure of Directors or Certain Officers
4:15pm
424B4
jtiojso3opp7151
19 Jun 19
Prospectus supplement with pricing info
5:25pm